ACT001 inhibits pituitary tumor growth by inducing autophagic cell death via MEK4/MAPK pathway
- 26 January 2022
- journal article
- research article
- Published by Springer Nature in Acta Pharmacologica Sinica
- Vol. 43 (9) , 2386-2396
Abstract
ACT001, derived from traditional herbal medicine, is a novel compound with effective anticancer activity in clinical trials. However, little is known regarding its role in pituitary adenomas. Here, we demonstrated that ACT001 suppressed cell proliferation and induced cell death of pituitary tumor cells in vitro and in vivo. ACT001 was also effective in suppressing the growth of different subtypes of human pituitary adenomas. The cytotoxic mechanism ACT001 employed was mainly related to autophagic cell death (ACD), indicated by autophagosome formation and LC3-II accumulation. In addition, ACT001-mediated inhibitory effect decreased when either ATG7 was downregulated or cells were cotreated with autophagy inhibitor 3-methyladenine (3-MA). RNA-seq analysis showed that mitogen-activated protein kinase (MAPK) pathway was a putative target of ACT001. Specifically, ACT001 treatment promoted the phosphorylation of JNK and P38 by binding to mitogen-activated protein kinase kinase 4 (MEK4). Our study indicated that ACT001-induced ACD of pituitary tumor cells via activating JNK and P38 phosphorylation by binding with MEK4, and it might be a novel and effective anticancer drug for pituitary adenomas.Keywords
This publication has 47 references indexed in Scilit:
- Synthesis of Micheliolide Derivatives and Their Activities against AML Progenitor CellsMolecules, 2013
- Cell context‐dependent activities of parthenolide in primary and metastatic melanoma cellsBritish Journal of Pharmacology, 2010
- Genes Differentially Expressed in Prolactinomas Responsive and Resistant to Dopamine AgonistsNeuroendocrinology, 2008
- Ras/Erk MAPK Signaling in Epidermal Homeostasis and NeoplasiaCell Cycle, 2007
- Role of mitogen-activated protein kinase kinase 4 in cancerOncogene, 2007
- Guidelines of the Pituitary Society for the diagnosis and management of prolactinomasClinical Endocrinology, 2006
- Characterization of the Structure and Function of the Fourth Member of p38 Group Mitogen-activated Protein Kinases, p38δJournal of Biological Chemistry, 1997
- Mitogen-activated protein kinase cascades and regulation of gene expressionCurrent Opinion in Immunology, 1996
- PRODUCTION OF BOTH PROLACTIN AND GROWTH HORMONE BY CLONAL STRAINS OF RAT PITUITARY TUMOR CELLSJournal of Cell Biology, 1970
- CONTROL OF GROWTH HORMONE PRODUCTION BY A CLONAL STRAIN OF RAT PITUITARY CELLSJournal of Cell Biology, 1969